Cargando…
Cardiotoxicity due to targeted anticancer agents: a growing challenge
The emergence of various targeted anticancer agents has led us to uncharted territory secondary to their cardiotoxic potential with many burning questions, which in turn has led to the evolution of the cardio-oncology field. These targeted agents differ in their cardiovascular complication (CVC) pot...
Autores principales: | Shah, Chintan P., Moreb, Jan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475850/ https://www.ncbi.nlm.nih.gov/pubmed/30995890 http://dx.doi.org/10.1177/1753944719843435 |
Ejemplares similares
-
Cardiotoxicity of Contemporary Anticancer Immunotherapy
por: Dal’bo, Natalie, et al.
Publicado: (2020) -
Cardiotoxicity of Anticancer Therapeutics
por: Dong, Jerry, et al.
Publicado: (2018) -
Cardiotoxicity of Molecularly Targeted Agents
por: Hedhli, Nadia, et al.
Publicado: (2011) -
Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments
por: Audebrand, Anais, et al.
Publicado: (2020) -
Cardiotoxicity due to chemotherapy for breast cancer: The dark side of the moon
por: Peruzzi, Mariangela, et al.
Publicado: (2015)